SI21232A - Postopek za pripravo izredno čiste farmacevtske vmesne spojine, 4-(ciklopropilkarbonil)-alfa, alfa-dimetilfenilocetne kisline - Google Patents

Postopek za pripravo izredno čiste farmacevtske vmesne spojine, 4-(ciklopropilkarbonil)-alfa, alfa-dimetilfenilocetne kisline Download PDF

Info

Publication number
SI21232A
SI21232A SI200220003A SI200220003A SI21232A SI 21232 A SI21232 A SI 21232A SI 200220003 A SI200220003 A SI 200220003A SI 200220003 A SI200220003 A SI 200220003A SI 21232 A SI21232 A SI 21232A
Authority
SI
Slovenia
Prior art keywords
formula
alpha
mixture
meta
preparation
Prior art date
Application number
SI200220003A
Other languages
English (en)
Slovenian (sl)
Inventor
Dandala Ramesh
Das Umashankar
Venkata Naga Srinivasa Rao Divvela
Sunderam Sivakumaran Meenakshi
Original Assignee
Aurobindo Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Limited filed Critical Aurobindo Pharma Limited
Publication of SI21232A publication Critical patent/SI21232A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200220003A 2001-06-25 2002-06-19 Postopek za pripravo izredno čiste farmacevtske vmesne spojine, 4-(ciklopropilkarbonil)-alfa, alfa-dimetilfenilocetne kisline SI21232A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN511CH2001 2001-06-25
PCT/IN2002/000135 WO2003000658A1 (en) 2001-06-25 2002-06-19 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID

Publications (1)

Publication Number Publication Date
SI21232A true SI21232A (sl) 2003-12-31

Family

ID=29765111

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200220003A SI21232A (sl) 2001-06-25 2002-06-19 Postopek za pripravo izredno čiste farmacevtske vmesne spojine, 4-(ciklopropilkarbonil)-alfa, alfa-dimetilfenilocetne kisline

Country Status (7)

Country Link
US (1) US6903232B2 (cg-RX-API-DMAC10.html)
EP (1) EP1401815A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004521942A (cg-RX-API-DMAC10.html)
BG (1) BG107476A (cg-RX-API-DMAC10.html)
SI (1) SI21232A (cg-RX-API-DMAC10.html)
SK (1) SK712003A3 (cg-RX-API-DMAC10.html)
WO (1) WO2003000658A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
WO2003104197A1 (en) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
DE102004031849A1 (de) 2004-06-30 2006-01-26 Sanofi-Aventis Deutschland Gmbh Verfahren zur Carbonylierung von Phenylalkylderivaten mit Kohlenmonoxid
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
RS59874B1 (sr) 2015-10-22 2020-03-31 Sanofi Aventis Deutschland Proces za pripremu feksofenadina i njegovih intermedijara

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DK1026147T3 (da) * 1993-06-24 2004-03-22 Albany Molecular Res Inc Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater

Also Published As

Publication number Publication date
EP1401815A1 (en) 2004-03-31
US6903232B2 (en) 2005-06-07
SK712003A3 (en) 2003-12-02
WO2003000658A1 (en) 2003-01-03
US20040077900A1 (en) 2004-04-22
BG107476A (bg) 2004-01-30
JP2004521942A (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
AU612621B2 (en) Benzoylpiperidines and benzoylpiperidine oxides and oximes and their preparation
RU2160731C2 (ru) Промежуточные продукты для получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина, способы их получения и способ получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина с их применением
CN1434800A (zh) 吡啶-1-氧化物衍生物及其转化为药物活性化合物的方法
JP4344230B2 (ja) ピペリジン誘導体フェキソフェナジンの製造方法
JP5585822B2 (ja) 光学活性ニペコチン酸誘導体の製造方法
US6903232B2 (en) Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-α, α-dimethylphenylacetic acid
US7446203B2 (en) Preparation of intermediates for acetycholinesterase inhibitors
WO2002102777A2 (en) NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
JP2012025705A (ja) (s)−4−〔(4−クロロフェニル)(2−ピリジル)メトキシ〕ピペリジンのジアステレオマー塩の製造方法
JP2004521942A5 (cg-RX-API-DMAC10.html)
EP1347960B1 (en) Process for preparing (+) trans-4-p-fluorophenyl-3-hydroxymethyl-1
CN1251574A (zh) O-(3-氨基-2-羟基-丙基)-肟酰卤类的制备方法
EP1867635A1 (en) Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
JPH0681743B2 (ja) α−(アルキルフェニル)−4−(ヒドロキシジフェニルメチル)−1−ピペリジンブタノールの製造方法
JP2003502422A (ja) パロキセチンおよび構造上関連する化合物の製法
US20130059886A1 (en) Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation
AU2008202097A1 (en) A Process for the Preparation of Keto Compounds
WO2006092809A1 (en) PROCESS FOR PRODUCING POLYMORPH FORM (I) OF l-BENZYL-4- [(5, 6-DIMETHOXY-l-INDANONE) -2YL] METHYL PIPERIDINE HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)
RU2155752C2 (ru) Способы получения производных 1,4-дигидропиридин-3,5-дикарбоновой кислоты в виде r-изомеров и их солей, исходные и промежуточные продукты для их получения
JP2672939B2 (ja) N−アリル−2,5−ジメチル−ピペリジノール−4−ベンゾイルエステルの製造方法
JP4441260B2 (ja) 4−アミノ−4−フェニルピペリジン類の製造方法
KR19990008135A (ko) (-)-트랜스-엔-피-플루오르벤조일메틸-4-(피-플루오르페닐)-3-[[3,4-(메틸렌디옥시)페녹시]메틸]-피페리딘의 제조방법
CN1204319A (zh) 制备1-苄基-4-(5,6-二甲氧基-1-二氢化茚酮)-2-基)甲基哌啶的方法和中间体
JPS59190980A (ja) 2’−クロロ−3−アミノ−2−メチル置換プロピオフエノン誘導体

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20060404